Statistics for Sangamo Therapeutics (id:8154 SGMO)

Valuation metrics

Market cap

396.43M

Enterprise value

415.63M

Trailing P/E (ttm)

-1.27

Forward P/E

-8.64

PEG ratio

-8.64

Price/Sales (ttm)

7.58

Price/Book (mrq)

10.11

Enterprise Value/Revenue

7.95

Enterprise Value/EBITDA

-3.55

Overview

Shares outstanding

208.62M

Float

189.70M

Shares short

18.98M

% Held by insiders

0.02%

% Held by institutions

0.27%

Average volume (10 days)

10.31M

Average volume (90 days)

Price summary

52-Week low

0.30

52-Week high

3.18

52-Week change

80.32%

Beta

1.10

50-Day moving average

1.33

200-Day moving average

0.84

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-257.86%

Operating margin

21.52%

Operational effectiveness

Return on assets

-46.35%

Return on equity

-154.94%

Income statement

Revenue (ttm)

0.27

Revenue per share (ttm)

0.27

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

58.21M

Net income to common (ttm)

-134,840,000.00

Diluted EPS (ttm)

-1.38

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

39.20M

Total cash per share (mrq)

0.19

Total debt (mrq)

27.73M

Total Debt/Equity (mrq)

70.85

Current ratio (mrq)

134.70%

Book value per share (mrq)

0.19

Cash flow

Cash flow statement

-114,326,000.00

Levered free cash flow (LFCF)

-71,930,624.00